Literature DB >> 32924688

Prognostic impact of serum CXC chemokine ligands 4 and 7 on myelodysplastic syndromes post allogeneic hematopoietic cell transplant.

Binod Dhakal1, Tao Wang2,3, Michelle Kuxhausen4, Fenlu Zhu1, Carolyn Taylor1, Stephen R Spellman4, Michael R Verneris5, Katharine Hsu6, Katharina Fleischhauer7, Stephanie J Lee8, Yung-Tsi Bolon4, Karen-Sue Carlson1, Aziz Nazha9, Wael Saber2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32924688      PMCID: PMC7939047          DOI: 10.1080/10428194.2020.1817446

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


× No keyword cloud information.
  15 in total

1.  Revised international prognostic scoring system for myelodysplastic syndromes.

Authors:  Peter L Greenberg; Heinz Tuechler; Julie Schanz; Guillermo Sanz; Guillermo Garcia-Manero; Francesc Solé; John M Bennett; David Bowen; Pierre Fenaux; Francois Dreyfus; Hagop Kantarjian; Andrea Kuendgen; Alessandro Levis; Luca Malcovati; Mario Cazzola; Jaroslav Cermak; Christa Fonatsch; Michelle M Le Beau; Marilyn L Slovak; Otto Krieger; Michael Luebbert; Jaroslaw Maciejewski; Silvia M M Magalhaes; Yasushi Miyazaki; Michael Pfeilstöcker; Mikkael Sekeres; Wolfgang R Sperr; Reinhard Stauder; Sudhir Tauro; Peter Valent; Teresa Vallespi; Arjan A van de Loosdrecht; Ulrich Germing; Detlef Haase
Journal:  Blood       Date:  2012-06-27       Impact factor: 22.113

2.  Serum evaluation of angiogenic cytokine basic fibroblast growth factor, hepatocyte growth factor and TNF-alpha in patients with myelodysplastic syndromes: correlation with bone marrow microvascular density.

Authors:  M G Alexandrakis; F H Passam; C A Pappa; J Damilakis; G Tsirakis; E Kandidaki; A M Passam; E N Stathopoulos; D S Kyriakou
Journal:  Int J Immunopathol Pharmacol       Date:  2005 Apr-Jun       Impact factor: 3.219

3.  Platelet proteome analysis reveals integrin-dependent aggregation defects in patients with myelodysplastic syndromes.

Authors:  Julia Fröbel; Ron-Patrick Cadeddu; Sonja Hartwig; Ingmar Bruns; Christian M Wilk; Andrea Kündgen; Johannes C Fischer; Thomas Schroeder; Ulrich G Steidl; Ulrich Germing; Stefan Lehr; Rainer Haas; Akos Czibere
Journal:  Mol Cell Proteomics       Date:  2013-02-04       Impact factor: 5.911

4.  Defining the intensity of conditioning regimens: working definitions.

Authors:  Andrea Bacigalupo; Karen Ballen; Doug Rizzo; Sergio Giralt; Hillard Lazarus; Vincent Ho; Jane Apperley; Shimon Slavin; Marcelo Pasquini; Brenda M Sandmaier; John Barrett; Didier Blaise; Robert Lowski; Mary Horowitz
Journal:  Biol Blood Marrow Transplant       Date:  2009-09-01       Impact factor: 5.742

5.  Peripheral blood mononuclear cell proteome changes in patients with myelodysplastic syndrome.

Authors:  Klara Pecankova; Pavel Majek; Jaroslav Cermak; Jan E Dyr
Journal:  Biomed Res Int       Date:  2015-04-16       Impact factor: 3.411

6.  Proteome changes in the plasma of myelodysplastic syndrome patients with refractory anemia with excess blasts subtype 2.

Authors:  Pavel Majek; Zuzana Riedelova-Reicheltova; Jiri Suttnar; Klara Pecankova; Jaroslav Cermak; Jan E Dyr
Journal:  Dis Markers       Date:  2014-05-25       Impact factor: 3.434

7.  Megakaryocytes regulate hematopoietic stem cell quiescence through CXCL4 secretion.

Authors:  Ingmar Bruns; Daniel Lucas; Sandra Pinho; Jalal Ahmed; Michele P Lambert; Yuya Kunisaki; Christoph Scheiermann; Lauren Schiff; Mortimer Poncz; Aviv Bergman; Paul S Frenette
Journal:  Nat Med       Date:  2014-10-19       Impact factor: 53.440

8.  Proteomic Analysis Reveals Autophagy as Pro-Survival Pathway Elicited by Long-Term Exposure with 5-Azacitidine in High-Risk Myelodysplasia.

Authors:  Alessandra Romano; Cesarina Giallongo; Piera La Cava; Nunziatina L Parrinello; Antonella Chiechi; Calogero Vetro; Daniele Tibullo; Francesco Di Raimondo; Lance A Liotta; Virginia Espina; Giuseppe A Palumbo
Journal:  Front Pharmacol       Date:  2017-04-26       Impact factor: 5.810

9.  Plasma protein alterations in the refractory anemia with excess blasts subtype 1 subgroup of myelodysplastic syndrome.

Authors:  Pavel Májek; Zuzana Reicheltová; Jiří Suttnar; Jaroslav Cermák; Jan E Dyr
Journal:  Proteome Sci       Date:  2012-05-08       Impact factor: 2.480

10.  Quantitative proteomic analysis of histone modifications in decitabine sensitive and resistant leukemia cell lines.

Authors:  Chunchao Zhang; Jinfeng Suo; Hiroyuki Katayama; Yue Wei; Guillermo Garcia-Manero; Samir Hanash
Journal:  Clin Proteomics       Date:  2016-07-05       Impact factor: 3.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.